<--- Back to Details
First PageDocument Content
Microbiology / Tuberculosis treatment / Multi-drug-resistant tuberculosis / Latent tuberculosis / 4-Aminosalicylic acid / Multiple drug resistance / Drug resistance / Mycobacterium / Directly Observed Therapy – Short Course / Tuberculosis / Bacteria / Medicine
Date: 2013-11-30 20:29:15
Microbiology
Tuberculosis treatment
Multi-drug-resistant tuberculosis
Latent tuberculosis
4-Aminosalicylic acid
Multiple drug resistance
Drug resistance
Mycobacterium
Directly Observed Therapy – Short Course
Tuberculosis
Bacteria
Medicine

Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis

Add to Reading List

Source URL: www.theunion.org

Download Document from Source Website

File Size: 1,76 MB

Share Document on Facebook

Similar Documents

Tuberculosis / Extensively drug-resistant tuberculosis / Tuberculosis management / Multi-drug-resistant tuberculosis / Latent tuberculosis / DOTS / 4-Aminosalicylic acid / Ethionamide / Rifampicin / Isoniazid / Mycobacterium tuberculosis / Bedaquiline

NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES Division of the National Health Laboratory Service South African Tuberculosis Drug Resistance Survey

DocID: 1oCOE - View Document

Microbiology / Tuberculosis treatment / Extensively drug-resistant tuberculosis / Multi-drug-resistant tuberculosis / Antibiotic resistance / Totally drug-resistant tuberculosis / Drug resistance / Pyrazinamide / 4-Aminosalicylic acid / Tuberculosis / Medicine / Bacteria

Whatʼs in a name? The future of drug-resistant tuberculosis classification Timothy Sullivan, Yanis Ben Amor Due to a recent resurgence in tuberculosis research focused on drug development, several new antituberculosis d

DocID: 17jlg - View Document

Gastroenterology / Salicylic acids / Abdominal pain / Colitis / Management of ulcerative colitis / Ulcerative colitis / Mesalazine / Inflammatory bowel disease / 4-Aminosalicylic acid / Medicine / Health / Autoimmune diseases

Aliment Pharmacol Ther 2005; 21: 1111–doi: j02458.x Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients

DocID: 15ms7 - View Document

Microbiology / Extensively drug-resistant tuberculosis / Multi-drug-resistant tuberculosis / Tuberculosis treatment / Directly Observed Therapy – Short Course / Isoniazid / AIDS / 4-Aminosalicylic acid / Rifampicin / Tuberculosis / Medicine / Health

MAJOR ARTICLE Extensively Drug-Resistant Tuberculosis in California, 1993–2006 Ritu Banerjee,1 Jennifer Allen,2 Janice Westenhouse,2 Peter Oh,2 William Elms,2 Ed Desmond,3 Annette Nitta,4 Sarah Royce,2 and Jennifer Fl

DocID: 154Lk - View Document

Microbiology / Tuberculosis treatment / Multi-drug-resistant tuberculosis / Latent tuberculosis / 4-Aminosalicylic acid / Multiple drug resistance / Drug resistance / Mycobacterium / Directly Observed Therapy – Short Course / Tuberculosis / Bacteria / Medicine

Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis

DocID: 1391p - View Document